Wegovy is administered as a subcutaneous injection once weekly, into the abdomen, thigh, or upper arm
Tirzepatide (weekly injection) is a dual GIP/GLP-1 agonist that may produce even greater results
Growth hormone & IGF research: official journal of the Growth Hormone Research Society and the International IGF Research Society, 19(5), 426431
Victoza (liraglutide) is FDA-approved to reduce the risk of major cardiovascular events like heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and known heart disease
Yes, rapid improvement in glycemic control with any diabetes medication can occasionally trigger treatment-induced neuropathy of diabetes, which presents as acute painful neuropathy and typically improves over time